Effectiveness of strategies for preventing acute antineoplastic-induced nausea and vomiting in children with acute lymphoblastic leukemia

Canadian Journal of Hospital Pharmacy

Volumn 52, Issue 6, 1999, Pages 350-361

  Dupuis, L Lee ^a,b   Lau, Robert ^a   Greenberg, Mark L ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antiemetic agents; Antineoplastic induced vomiting; Leukemia; Pediatrics

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DIMENHYDRINATE; DOXORUBICIN; METHOTREXATE; METOCLOPRAMIDE; ONDANSETRON; VINCRISTINE;

ABDOMINAL PAIN; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BACKACHE; CHILD; CHILDHOOD LEUKEMIA; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIET; DRUG CHOICE; DRUG EFFICACY; FATIGUE; FEMALE; HEADACHE; HICCUP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRACTICE GUIDELINE; PRURITUS; VOMITING;

EID: 0033512220     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dupuis L, Chan HSL, Lacey C, McBride J. The management of chemotherapy-induced nausea and vomiting in children. Can J Hosp Pharm 1986;39:38-40.
2. Wong D, Baker C. Pain in children: comparison of assessment scales. Pediatr Nurs 1988;14:9-17.
3. Nolte MJ, Berkery R, Pizzo B, Baltzer L, Grossano D, Lucarelli CD, et al. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center. J Clin Oncol 1998;16:771-8.
4. Foot ABM, Hayes C. Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis. Arch Dis Child 1994;71:475-80.
5. Hesketh PJ, Kris MG, Grunberg SM, Beck T, Hainsworth JD, Harker G, et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;15:103-9.
6. Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer 1990;65:1717-21.
7. Gaynon PS, Lustig RH. The use of glucocorticoids in acute lymphoblastic leukemia of childhood: molecular, cellular, and clinical considerations. J Pediatr Hematol Oncol 1995;17:1-12.
8. Ito C, Evans W, McNinch L, Coustan-Smith E, Mahmoud H, Pui C-H, et al. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 1996;14:2370-6.
9. Faber OK, Mouridsen HT. Cyclophosphamide activation and corticosteroids [letter]. New Engl J Med 1974;291:211.
10. Weller M, Schmidt C, Roth W, Dichgans J. Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone? Neurology 1997;48:1704-9.
11. Moertel CG, Reitemeier RK, Gage RP. A controlled clinical evaluation of antiemetic drugs. JAMA 1963;186:116-8.
12. Morran C, Smith DC, Anderson DA, McArdle CS. Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics. BMJ 1979;1:1323-4.
13. Billett AL, Sallan SE. Antiemetics in children receiving cancer chemotherapy. Support Care Cancer 1994;2:279-85.
14. Osoba D, Warr DG, Fitch MI, Nakashimia L, Warren B. Guidelines for the optimal management of chemotherapy-induced nausea and vomiting: a concensus. Can J Oncol 1995;5:381-400.
15. Tyc VL, Mulhem RK, Barclay DR, Smith BF, Bieberich AA. Variables associated with anticipatory nausea and vomiting in pediatric cancer patients receiving ondansetron antiemetic therapy. J Pediatr Psychol 1997;22:45-58.
16. Morrow GR, Roscoe JA, Hickok JT, Stem RM, Pierce HI, King DB, et al. Initial control of chemotherapy-induced nausea and vomiting in patient quality of life. Oncology 1998;12 (Suppl 4):32-7.
17. Alvarez O, Freeman A, Bedros A, Call SK, Volsch J, Kalbermatter O, et al. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pcdiatr Hematol Oncol 1995;17:145-50.
18. 2. Eur J Cancer 1996;32A:1744-8.
19. Stevens R, Voltan B, Lane R, Schaison G. A randomized study of ondansetron syrup in children: evaluation of taste acceptability and tolerance. Pediatr Hematol Oncol 1996;13:199-202.
20. de Boer-Dennert M, de Wit R, Schmitz PIM, Djontono J, Beurden V, Stoter G, et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 1997;76:1055-61.